Israel Englander Esperion Therapeutics, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 961,035 shares of ESPR stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
961,035
Previous 829,885
15.8%
Holding current value
$1.19 Million
Previous $1.83 Million
24.22%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ESPR
# of Institutions
202Shares Held
119MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$14.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.9MShares$13.6 Million0.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$12 Million0.32% of portfolio
-
Two Seas Capital LP Rye, NY6.93MShares$8.59 Million0.36% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $82.5M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...